Relmada Therapeutics (RLMD) Short-Term Debt issuances (2019 - 2020)

Relmada Therapeutics (RLMD) reported Short-Term Debt issuances of -$110247.0 for Q1 2020, down 28.24% year-over-year from -$153633.8 in Q2 2019, and up 50.57% quarter-over-quarter from -$223017.0 in Q3 2019.

Relmada Therapeutics (RLMD) Short-Term Debt issuances (2019 - 2020) Analysis & Trends

Relmada Therapeutics (RLMD) has 2 years of Short-Term Debt issuances data on file, last reported at -$110247.0 in Q1 2020.

  • Short-Term Debt issuances for Q1 2020 came in at -$110247.0, down 28.24% year-over-year; the trailing twelve-month figure through Sep 2020 was -$333264.0 (changed N/A YoY), and the FY2019 annual result was -$285170.0, down 3454.94% from the prior year.
  • Short-Term Debt issuances climbed to -$110247.0 in Q1 2020 per RLMD's latest filing, from -$223017.0 in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at -$85969.0 in Q1 2019 and troughed at -$223017.0 in Q3 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -33,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Relmada Therapeutics 581.07 Mn 581.07 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -110,247.00
Mar 31, 2020 -110,247.00
Sep 30, 2019 -223,017.00
Sep 30, 2019 -223,017.00
Jun 30, 2019 -114,738.00
Jun 30, 2019 -114,738.00
Mar 31, 2019 -85,969.00
Mar 31, 2019 -85,969.00